What is GEHC revenue?

GE HealthCare Technologies Inc. (GEHC) reported $21.64B of revenue for the twelve months ended Sep 30, 2026. That is up 6.9% from the year before. Revenue for fiscal 2025 was $20.63B.

Yes. GE HealthCare Technologies Inc. earned $2.15B in net income for the twelve months ended Sep 30, 2026, a net margin of 10.0%.

How much cash and debt does GEHC have?

GE HealthCare Technologies Inc. reported $2.83B in cash and cash equivalents and $9.97B of debt on its most recent balance sheet in SEC filings.

How fast is GEHC revenue growing?

GE HealthCare Technologies Inc.'s revenue changed +4.8% in fiscal 2025, to $20.63B.

What is GEHC gross margin?

GE HealthCare Technologies Inc.'s gross profit was $8.64B on $21.64B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 39.9%.

What is GEHC free cash flow?

GE HealthCare Technologies Inc. generated $1.89B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $2.42B less capital expenditures.

What is GEHC earnings per share?

Diluted earnings per share were $4.73 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did GEHC last report financial results?

The latest statements here come from GE HealthCare Technologies Inc.'s 10-Q filed on Oct 28, 2026, covering the period ended Sep 30, 2026.

Financials · GEHC

GE HealthCare Technologies Inc. (GEHC) financials

For the twelve months ended Sep 30, 2026, GE HealthCare Technologies Inc. reported $21.64B of revenue and $2.15B of net income.

Revenue, TTM: $21.64B
Revenue growth, YoY: +6.9%
Net income, TTM: $2.15B
Net income growth, YoY: -2.8%
Net margin: 10.0%
Free cash flow, TTM: $1.89B
EPS, diluted, TTM: $4.73
EPS growth, YoY: -2.5%
Cash: $2.83B
Total debt: $9.97B
P/E: 17.29
P/S: 1.72
Market cap: $37.25B

Annual revenue$20.63B

FY2021FY2025

Annual net income$2.08B

FY2021FY2025

Annual free cash flow$1.50B

FY2021FY2025

GEHC revenue and earnings growth

GEHC revenueQ3 2026$5.51B

Quarter YoY: +7.2%
QoQ: +4.1%
FY YoY: +4.8%

GEHC revenue was $5.51B in fiscal Q3 2026 (ended Sep 30, 2026), up 7.2% from a year earlier and up 4.1% from the prior quarter. For the full fiscal 2025 it was $20.63B, up 4.8% from fiscal 2024. It rose in each of the last 4 fiscal years. Fiscal 2025 is the highest of the 5 fiscal years on file.

GEHC net incomeQ3 2026$615.00M

Quarter YoY: +37.9%
QoQ: +9.6%
FY YoY: +4.6%

GEHC net income was $615.00M in fiscal Q3 2026 (ended Sep 30, 2026), up 37.9% from a year earlier and up 9.6% from the prior quarter. For the full fiscal 2025 it was $2.08B, up 4.6% from fiscal 2024. It rose in 2 of the last 4 fiscal years.

GEHC EPSQ3 2026$1.36

Quarter YoY: +38.8%
QoQ: +9.7%
FY YoY: +4.8%

GEHC diluted EPS was $1.36 in fiscal Q3 2026 (ended Sep 30, 2026), up 38.8% from a year earlier and up 9.7% from the prior quarter. For the full fiscal 2025 it was $4.55, up 4.8% from fiscal 2024.

GEHC free cash flowQ3 2026$793.00M

Quarter YoY: +64.2%
QoQ: 12x
FY YoY: -3.2%

GEHC free cash flow was $793.00M in fiscal Q3 2026 (ended Sep 30, 2026), up 64.2% from a year earlier and up about 12-fold from the prior quarter. For the full fiscal 2025 it was $1.50B, down 3.2% from fiscal 2024. It rose in 1 of the last 4 fiscal years.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021
Revenue	$20.63B	$19.67B	$19.55B	$18.34B	$17.59B
Gross profit	$8.25B	$8.21B	$7.92B	$7.18B	$7.17B
Research and development	$1.26B	$1.31B	$1.21B	$1.03B	$816.00M
Selling, general and admin	$4.22B	$4.27B	$4.28B	$3.63B	$3.56B
Operating income	$2.76B	$2.63B	$2.44B	$2.52B	$2.79B
Pre-tax income	$2.77B	$2.58B	$2.36B	$2.51B	$2.88B
Income tax	$614.00M	$531.00M	$743.00M	$563.00M	$600.00M
Net income	$2.08B	$1.99B	$1.57B	$1.92B	$2.25B
EPS, basic	$4.56	$4.37	$3.05	$4.22	$4.95
EPS, diluted	$4.55	$4.34	$3.03	$4.22	$4.95
Diluted shares	458.0M	459.0M	458.0M	454.0M	454.0M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021
Cash and equivalents	$4.49B	$2.89B	$2.51B	$1.45B	$561.00M
Inventory	$2.23B	$1.94B	$1.96B	$2.15B	-
Current assets	$12.50B	$9.90B	$9.41B	$8.32B	-
Goodwill	$13.49B	$13.14B	$12.94B	$12.81B	$12.89B
Total assets	$36.91B	$33.09B	$32.45B	$27.54B	-
Current liabilities	$9.11B	$9.55B	$8.98B	$7.19B	-
Short-term debt	$502.00M	$1.50B	$1.00B	$15.00M	-
Long-term debt	$9.49B	$7.45B	$8.44B	$8.23B	-
Total debt	$10.00B	$8.95B	$9.44B	$8.25B	-
Total liabilities	$26.31B	$24.44B	$25.14B	$17.95B	-
Shareholders' equity	$10.38B	$8.46B	$7.14B	$9.36B	$16.68B

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021
Operating cash flow	$1.99B	$1.96B	$2.10B	$2.13B	$1.61B
Capital expenditures	$482.00M	$401.00M	$387.00M	$310.00M	$248.00M
Free cash flow	$1.50B	$1.55B	$1.71B	$1.82B	$1.36B
Investing cash flow	-$1.05B	-$914.00M	-$558.00M	-$398.00M	-$1.76B
Financing cash flow	$617.00M	-$573.00M	-$478.00M	-$822.00M	-$263.00M
Dividends paid	$64.00M	$55.00M	$41.00M	$0	$0
Share repurchases	$200.00M	$0	$0	-	-
Stock-based compensation	$130.00M	$125.00M	$114.00M	$67.00M	$76.00M

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021
Revenue growth, YoY	4.8%	0.6%	6.6%	4.3%	-
Net income growth, YoY	4.6%	27.1%	-18.2%	-14.7%	-
EPS growth, YoY	4.8%	43.2%	-28.2%	-14.7%	-
Gross margin	40.0%	41.7%	40.5%	39.1%	40.8%
Operating margin	13.4%	13.3%	12.5%	13.8%	15.9%
Net margin	10.1%	10.1%	8.0%	10.4%	12.8%
Free cash flow margin	7.3%	7.9%	8.8%	9.9%	7.7%
Return on equity	20.1%	23.5%	21.9%	20.5%	13.5%
Return on assets	5.6%	6.0%	4.8%	7.0%	-
Current ratio	1.37	1.04	1.05	1.16	-
Debt to equity	0.96	1.06	1.32	0.88	-

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue	$5.51B	$5.29B	$5.13B	$5.70B	$5.14B	$5.01B	$4.78B	$5.32B	$4.86B	$4.84B	$4.65B	$5.21B
Gross profit	$2.22B	$2.18B	$1.98B	$2.26B	$1.99B	$1.99B	$2.01B	$2.27B	$2.03B	$2.00B	$1.90B	$2.16B
Research and development	$320.00M	$323.00M	$345.00M	$323.00M	$292.00M	$302.00M	$344.00M	$344.00M	$316.00M	$327.00M	$324.00M	$315.00M
Selling, general and admin	$1.10B	$1.12B	$1.12B	$1.11B	$1.04B	$1.03B	$1.04B	$1.13B	$1.03B	$1.07B	$1.04B	$1.15B
Operating income	$805.00M	$739.00M	$515.00M	$827.00M	$653.00M	$654.00M	$629.00M	$801.00M	$676.00M	$608.00M	$540.00M	$689.00M
Pre-tax income	$752.00M	$693.00M	$505.00M	$821.00M	$643.00M	$613.00M	$692.00M	$834.00M	$658.00M	$578.00M	$512.00M	$609.00M
Income tax	$129.00M	$119.00M	$94.00M	$219.00M	$179.00M	$113.00M	$104.00M	$96.00M	$168.00M	$143.00M	$124.00M	$193.00M
Net income	$615.00M	$561.00M	$389.00M	$589.00M	$446.00M	$486.00M	$564.00M	$721.00M	$470.00M	$428.00M	$374.00M	$403.00M
EPS, basic	$1.36	$1.24	$0.85	$1.29	$0.98	$1.06	$1.23	$1.58	$1.03	$0.94	$0.82	$0.89
EPS, diluted	$1.36	$1.24	$0.85	$1.28	$0.98	$1.06	$1.23	$1.58	$1.02	$0.93	$0.81	$0.89
Diluted shares	453.0M	454.0M	457.0M	-	457.0M	458.0M	459.0M	-	459.0M	459.0M	459.0M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Cash and equivalents	$2.83B	$2.08B	$2.26B	$4.49B	$4.03B	$3.77B	$2.48B	$2.89B	$3.57B	$2.02B	$2.56B	$2.51B
Inventory	$2.63B	$2.48B	$2.35B	$2.23B	$2.30B	$2.28B	$2.16B	$1.94B	$2.12B	$2.02B	$1.99B	$1.96B
Current assets	$11.49B	$10.50B	$10.43B	$12.50B	$11.89B	$11.31B	$9.73B	$9.90B	$10.64B	$8.81B	$9.37B	$9.41B
Goodwill	$15.14B	$15.10B	$15.06B	$13.49B	$13.44B	$13.42B	$13.37B	$13.14B	$13.14B	$13.12B	$12.93B	$12.94B
Total assets	$38.37B	$37.25B	$37.13B	$36.91B	$36.13B	$35.50B	$33.59B	$33.09B	$33.85B	$31.85B	$32.21B	$32.45B
Current liabilities	$8.81B	$8.30B	$8.53B	$9.11B	$10.07B	$9.75B	$9.97B	$9.55B	$8.67B	$8.32B	$8.86B	$8.98B
Short-term debt	$2.00M	$2.00M	$2.00M	$502.00M	$2.00B	$2.00B	$2.00B	$1.50B	$1.00B	$1.00B	$1.00B	$1.00B
Long-term debt	$9.97B	$10.09B	$10.13B	$9.49B	$8.28B	$8.27B	$6.76B	$7.45B	$9.31B	$8.23B	$8.25B	$8.44B
Total debt	$9.97B	$10.09B	$10.13B	$10.00B	$10.28B	$10.27B	$8.76B	$8.95B	$10.31B	$9.24B	$9.25B	$9.44B
Total liabilities	$26.51B	$26.03B	$26.23B	$26.31B	$25.91B	$25.55B	$24.17B	$24.44B	$25.34B	$23.86B	$24.61B	$25.14B
Shareholders' equity	$11.61B	$10.99B	$10.68B	$10.38B	$10.02B	$9.73B	$9.21B	$8.46B	$8.34B	$7.82B	$7.42B	$7.14B

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Operating cash flow	$907.00M	$168.00M	$290.00M	$1.05B	$593.00M	$94.00M	$250.00M	$913.00M	$742.00M	-$119.00M	$419.00M	$1.05B
Capital expenditures	$114.00M	$100.00M	$178.00M	$134.00M	$110.00M	$86.00M	$152.00M	$102.00M	$90.00M	$64.00M	$145.00M	$94.00M
Free cash flow	$793.00M	$68.00M	$112.00M	$916.00M	$483.00M	$8.00M	$98.00M	$811.00M	$652.00M	-$183.00M	$274.00M	$956.00M
Investing cash flow	-$111.00M	-$115.00M	-$2.50B	-$269.00M	-$148.00M	-$223.00M	-$407.00M	-$240.00M	-$137.00M	-$349.00M	-$188.00M	-$88.00M
Financing cash flow	-$40.00M	-$236.00M	$21.00M	-$293.00M	-$165.00M	$1.36B	-$286.00M	-$1.28B	$914.00M	-$57.00M	-$153.00M	-$900.00M
Dividends paid	$16.00M	$16.00M	$16.00M	$16.00M	$16.00M	$16.00M	$16.00M	$14.00M	$13.00M	$14.00M	$14.00M	$13.00M
Share repurchases	$0	$200.00M	$100.00M	$0	$100.00M	$100.00M	$0	$0	$0	-	-	-
Stock-based compensation	$36.00M	$45.00M	$35.00M	$36.00M	$38.00M	$34.00M	$22.00M	$33.00M	$22.00M	$36.00M	$34.00M	$33.00M

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue growth, YoY	7.2%	5.8%	7.4%	7.1%	5.8%	3.5%	2.7%	2.2%	0.9%	0.5%	-1.2%	5.4%
Net income growth, YoY	37.9%	15.4%	-31.0%	-18.3%	-5.1%	13.6%	50.8%	78.9%	25.3%	2.4%	0.5%	-27.3%
EPS growth, YoY	38.8%	17.0%	-30.9%	-19.0%	-3.9%	14.0%	51.9%	77.5%	24.4%	2.2%	97.6%	-27.0%
Gross margin	40.3%	41.2%	38.5%	39.7%	38.7%	39.6%	42.1%	42.8%	41.7%	41.4%	40.9%	41.4%
Operating margin	14.6%	14.0%	10.0%	14.5%	12.7%	13.1%	13.2%	15.1%	13.9%	12.6%	11.6%	13.2%
Net margin	11.2%	10.6%	7.6%	10.3%	8.7%	9.7%	11.8%	13.6%	9.7%	8.8%	8.0%	7.7%
Free cash flow margin	14.4%	1.3%	2.2%	16.1%	9.4%	0.2%	2.1%	15.2%	13.4%	-3.8%	5.9%	18.4%
Current ratio	1.30	1.26	1.22	1.37	1.18	1.16	0.98	1.04	1.23	1.06	1.06	1.05
Debt to equity	0.86	0.92	0.95	0.96	1.03	1.06	0.95	1.06	1.24	1.18	1.25	1.32

Source: XBRL data GE HealthCare Technologies Inc. files with the SEC, latest filing dated Oct 28, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

GEHC peers

Company	Revenue	Growth	Net income	Net margin	Market cap
GEHC	$21.64B	+6.9%	$2.15B	10.0%	$37.25B
PHGKoninklijke Philips N.V. NY Registry Shares	€17.83B	-1.0%	€895.00M	5.0%	$29.83B
BFLYButterfly Network Inc.	$123.25M	+39.4%	-$53.69M	-43.6%	$1.70B
NNOXNANO-X IMAGING LTD	$13.02M	+15.4%	-$75.02M	-576.1%	$19.2M

GEHC FAQ

9 questions

What is GEHC revenue?
GE HealthCare Technologies Inc. (GEHC) reported $21.64B of revenue for the twelve months ended Sep 30, 2026. That is up 6.9% from the year before. Revenue for fiscal 2025 was $20.63B.
Is GEHC profitable?
Yes. GE HealthCare Technologies Inc. earned $2.15B in net income for the twelve months ended Sep 30, 2026, a net margin of 10.0%.
How much cash and debt does GEHC have?
GE HealthCare Technologies Inc. reported $2.83B in cash and cash equivalents and $9.97B of debt on its most recent balance sheet in SEC filings.
How fast is GEHC revenue growing?
GE HealthCare Technologies Inc.'s revenue changed +4.8% in fiscal 2025, to $20.63B.
What is GEHC gross margin?
GE HealthCare Technologies Inc.'s gross profit was $8.64B on $21.64B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 39.9%.
What is GEHC free cash flow?
GE HealthCare Technologies Inc. generated $1.89B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $2.42B less capital expenditures.
What is GEHC earnings per share?
Diluted earnings per share were $4.73 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did GEHC last report financial results?
The latest statements here come from GE HealthCare Technologies Inc.'s 10-Q filed on Oct 28, 2026, covering the period ended Sep 30, 2026.
Where does this GEHC financial data come from?
Quantisnow builds these statements from the structured XBRL data GE HealthCare Technologies Inc. files with the SEC. It is provided for information only and is not investment advice.